当前位置:首页 - 行情中心 - 迈普医学(301033) - 财务分析

迈普医学

(301033)

  

流通市值:31.86亿  总市值:37.86亿
流通股本:5597.76万   总股本:6651.94万

迈普医学(301033)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.24亿元,每股收益0.37元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益72795.44万元,未分配利润18236.53万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产81596.99万元,负债8801.55万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入73,703,893.55278,442,127.39190,940,750.31122,046,806.09
营业总成本48,479,325.85202,578,024.19139,545,635.6991,459,623.01
营业利润28,535,059.6891,722,045.5663,015,737.4138,585,955.08
利润总额28,315,992.3893,157,094.3862,687,733.8438,443,837.72
净利润24,162,30778,854,230.2352,802,976.3432,390,679.79
其他综合收益51,005.197,467.2670,664.75400.78
综合收益总额24,213,312.1978,861,697.4952,873,641.0932,391,080.57
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计300,948,007.36312,406,407.83285,882,172.38227,575,931.84
非流动资产合计515,021,909.02486,823,917.01458,590,954.05482,234,455.01
资产总计815,969,916.38799,230,324.84744,473,126.43709,810,386.85
流动负债合计37,478,975.3147,476,282.3145,121,454.6534,807,741.76
非流动负债合计50,536,544.5452,089,349.5736,082,093.8537,506,745.31
负债合计88,015,519.8599,565,631.8881,203,548.572,314,487.07
归属于母公司股东权益合计727,954,396.53699,664,692.96663,269,577.93637,495,899.78
股东权益合计727,954,396.53699,664,692.96663,269,577.93637,495,899.78
负债和股东权益合计815,969,916.38799,230,324.84744,473,126.43709,810,386.85
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计93,021,906.35341,053,216.86229,758,956.44149,917,430
经营活动现金流出小计63,817,159.32224,668,863.87166,381,601.41115,518,036.2
经营活动产生的现金流量净额29,204,747.03116,384,352.9963,377,355.0334,399,393.8
投资活动现金流入小计164,037,204.41436,529,989.6352,278,681.97262,033,917.06
投资活动现金流出小计221,823,777.22444,859,918.17320,357,241.08202,206,396.93
投资活动产生的现金流量净额-57,786,572.81-8,329,928.5731,921,440.8959,827,520.13
筹资活动现金流入小计-9,312,1929,312,192-
筹资活动现金流出小计510,502.290,981,760.189,597,454.1489,086,951.94
筹资活动产生的现金流量净额-510,502.2-81,669,568.1-80,285,262.14-89,086,951.94
汇率变动对现金及现金等价物的影响169,295.21156,134.77105,510.32216,957.71
现金及现金等价物净增加额-28,923,032.7726,540,991.0915,119,044.15,356,919.7
期末现金及现金等价物余额24,294,568.553,217,601.2741,795,654.2832,033,529.88
最新报告期:2025-06-16
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
信达证券唐爱金1.702.242.992025-06-16
华福证券王艳,黄冠群1.812.383.022025-05-26
华创证券郑辰,李婵娟1.702.373.332025-05-19
甬兴证券彭波,徐昕1.582.062.642025-05-07
中邮证券陈峻,蔡明子1.732.493.562025-05-07
TOP↑